A silicon-containing compound represented by Formula 1 and an organic electroluminescence device including the same in at least one of a plurality of organic layers of the device are provided.

##STR00001##

Object A problem to be solved by the present invention is to provide a luminescent nanocrystal complex that tends to disperse orderly in a polymer matrix and is superior in dispersibility in structurally mesogenic crosslinkable polymer matrices. Solution The present invention is a luminescent nanocrystal complex that contains luminescent nanocrystals and a surface-modifying compound that modifies the surface of the luminescent nanocrystals. The surface-modifying compound has a mesogenic backbone and a group that binds to the surface of the luminescent nanocrystals.

Disclosed are processes, systems, and reaction systems for the oligomerization of ethylene to form an oligomer product in a reaction zone using a catalyst system having i) a chromium component comprising an N.sup.2-phosphinyl amidine chromium compound complex, an N.sup.2-phosphinyl formamidine chromium compound complex, an N.sup.2-phosphinyl guanidine chromium compound complex, or any combination thereof, and ii) an aluminoxane. Ethylene can be contacted with an organic reaction medium to form an ethylene feedstock mixture prior to contact with the catalyst system. The ethylene feedstock mixture can be contacted with the catalyst system inside or outside of the reaction zone.

A composition comprising an N.sup.2-phosphinylamidine chromium salt complex having Structure FNPACr I: ##STR00001## wherein CrX.sub.p is a chromium salt where X is a monoanion and p is an integer from 2 to 6. A process comprising a) contacting i) ethylene, and ii) a catalyst system comprising an N.sup.2-phosphinylamidine chromium salt complex having Structure FNPACr I: ##STR00002## wherein CrX.sub.p is a chromium salt where X is a monoanion and p is an integer from 2 to 6; and b) forming an oligomer product in a reaction zone.

A composition comprising an N.sup.2-phosphinylamidine chromium salt complex having Structure FNPACr I: ##STR00001## wherein CrX.sub.p is a chromium salt where X is a monoanion and p is an integer from 2 to 6. A process comprising a) contacting i) ethylene, and ii) a catalyst system comprising an N.sup.2-phosphinylamidine chromium salt complex having Structure FNPACr I: ##STR00002## wherein CrX.sub.p is a chromium salt where X is a monoanion and p is an integer from 2 to 6; and b) forming an oligomer product in a reaction zone.

The present invention relates to a ligand compound, a catalyst system for oligomerization of olefins, and a method for oligomerization of olefins using the catalyst system. The catalyst system for oligomerization of olefins according to the present invention not only has excellent catalytic activity, but also exhibits high selectivity to 1-hexene or 1-octene, thus enabling more efficient preparation of alpha-olefin.

The present invention relates to a ligand compound, a catalyst system for oligomerization of olefins, and a method for oligomerization of olefins using the catalyst system. The catalyst system for oligomerization of olefins according to the present invention not only has excellent catalytic activity, but also exhibits high selectivity to 1-hexene or 1-octene, thus enabling more efficient preparation of alpha-olefin.

The present invention relates to an electrolytic solution for a magnesium battery, formed by mixing a compound represented by the following general formula (I), a Lewis acid or a compound represented by the following general formula (A), and a solvent; and the like.

##STR00001##

{In the formula, m represents 0 or 2, n represents 2 in a case of m=0 and represents 0 or 1 in a case of m=2, X.sup.1 represents a chlorine atom or a bromine atom, and two R.sup.1's each independently represent a magnesium chloride oxy group; a magnesium bromide oxy group; an alkyl group which may have a halogeno group or the like as a substituent; an alkoxy group; an aryl group which may have an alkoxy group or the like as a substituent; an aryloxy group which may have an alkoxy group or the like as a substituent; or a group represented by the following general formula (1), and two R.sup.1's may also form the following general formula (2).}

##STR00002##

(In the formula, four R.sup.10's each independently represent an alkyl group, a perfluoroalkyl group, a phenyl group, or a perfluorophenyl group.)

The invention includes a method of treating or preventing a Staphylococcus infection in a mammal or avian species in need thereof. The methods comprise administering to the mammal or avian species a therapeutically effective amount of fosmidomycin. In certain embodiments, the methods treat or prevent a drug-resistant Staphylococccus infection.

Disclosed are processes, systems, and reaction systems for the oligomerization of ethylene to form an oligomer product in a reaction zone using a catalyst system having i) a chromium component comprising an N.sup.2-phosphinyl amidine chromium compound complex, an N.sup.2-phosphinyl formamidine chromium compound complex, an N.sup.2-phosphinyl guanidine chromium compound complex, or any combination thereof, and ii) an aluminoxane. Ethylene can be contacted with an organic reaction medium to form an ethylene feedstock mixture prior to contact with the catalyst system. The ethylene feedstock mixture can be contacted with the catalyst system inside or outside of the reaction zone.